ADRC News

A graphic of Dr. Art Walaszek presenting at the Fall Community Conversation.

2024 Fall Community Conversation: The Impact of Social Connections on Brain Health

On Tuesday, September 10, from 4:30 to 7:30 p.m. the Wisconsin Alzheimer’s Disease Research Center (ADRC) will present the 2024 Fall Community Conversation: The Impact of Social Connections on Brain Health. Free and open to all, the event will provide information to help people stay connected, improve brain health, support memory and live healthier, happier lives.
Community-Clinical Linkages to Promote Brain Health graphic with white text on a purple background

New toolkit aids clinicians in reducing dementia risk factors

Maria Mora Pinzon, MD, MS, helped develop a newly released toolkit with support from the Centers for Disease Control (CDC) and others.
Aerial image of University Hospital in Madison, WI

UW–Madison Alzheimer’s disease research program featured in Madison Magazine

The article includes interviews with several scientists and faculty members from UW–Madison, including Cynthia Carlsson, MD, MS, and Nathaniel Chin, MD.
On the left is the headline, "IEA Innovation Fund awards $450,000 in first funding cycle across five recipients". Next to this headline is a drawing of a head with interconnected lines and nodes coming from it against a dark background, like stars in the sky.

IEA Innovation Fund awards $450,000 in first funding cycle across five recipients

The IEA Innovation Fund launched in 2023 to advance promising new ideas in UW–Madison Alzheimer’s Disease (AD) research and programming, enhance resources available to researchers and respond to innovative and emerging needs of this area of medicine.
Group of people exercising at the UW South Madison Partnership office

Connecting South Madison community to resources

The UW South Madison Partnership (UWSMP) is a community hub in the heart of Madison's south side that fosters collaboration between dozens of local groups, University of Wisconsin programs and other organizations. Annik Dupaty, MA, highlights the partnership's importance in making resources available to the community.
Doctor at a desk going over notes with a patient

Primary care needs boost for biomarker testing

Nathaniel Chin, MD, and Claire M. Erickson, PhD, MPA, co-wrote a guest essay recently featured in The New England Journal of Medicine (NEJM) asserting that primary care currently lacks the training and resources for biomarker testing and that more support is needed through infrastructural changes.
Dementia Matters logo on a white background with red and blue circles and ‘Dementia Matters’ Special Series Voices of Research Participants

‘Dementia Matters’ Special Series: Voices of Research Participants

Nathaniel Chin, MD, and Sarah Walter, MSc, co-host a special four-part series for the Dementia Matters podcast. The four compelling, informative installments center on people participating in Alzheimer’s disease research.
Graphic image noting the words FDA Approved

FDA approves Alzheimer’s disease drug donanemab

The treatment, also known as Kisunla, is the third and latest monoclonal antibody to receive FDA approval.
Dr. Nathaniel Chin in his office

Dr. Nathaniel Chin named among Wisconsin’s most influential Asian American leaders

Nathaniel Chin, MD, was recently named among Wisconsin’s most influential Asian American leaders for 2024 in a survey by Madison365. The fifth annual edition of the list highlights elected, business and community leaders making a difference across the state.
The UW crest behind some red and white tulips

UW leads the way in Alzheimer’s disease research

Renowned experts Sanjay Asthana, MD, Amy Kind, MD, PhD, and Nathaniel Chin, MD, from the Wisconsin Alzheimer’s Disease Research Center (ADRC) in the UW School of Medicine and Public Health (SMPH), recently shared their insights in The UW Now livestream and Q&A session.